期刊文献+

The changes of serum nitric oxide, angiotensin Ⅱ and superoxide anion in renal artery hypertension rat 被引量:6

The changes of serum nitric oxide, angiotensin Ⅱ and superoxide anion in renal artery hypertension rat
暂未订购
导出
摘要 Objectives To study the changes of nitric oxide, angiotensin Ⅱ and superoxide anion in renal artery hypertension pathogenesis. Methods Male Wistar rats weighing 256 -285g were divided into 5 groups randomly, 10 rats of each group. Control group: false operation was made and routine diet was given; Ligature group: left renal artery was ligatured uncompletely and routine diet was given; Ligature + Losartan group: left renal artery was ligatured uneompletely and Losartan 20mg · kg^(-1) · d^(-1) was added in the drinking water; Ligature + L -Arg group: left renal artery was ligatured uncompletely and L -Arg 2g · kg^(-1) · d^(-1) was added in the drinking water; Ligature + L - Arg + Losartan group: left renal artery was ligatured uncompletely and L - Arg 2g· kg^(-1)· d^(-1) and Losartan 20mg · kg^(-1)· d^(-1) was added in the drinking water. Blood pressure and heart rate were measured before and at the end of the experiment. One week after ligature, blood was drawn to determine angiotensin Ⅱ, cGMP, nitric oxide, nitric oxide synthase (NOS), O_2^-, superoxide dismutase (SOD). Results Systolic blood pressure was higher in ligature group than that in control group (p <0.05), systolic blood pressure was much lower in ligature + Losartan group than that in ligature group. Heart rate did not change significantly after experiment (p > 0. 05). AngⅡ was higher in ligature group than that in control group, even much higher in ligature + Losartan group (p < 0. 01 ). There was no difference of cGMP in each group (p >. 05). The concentration of NO was lower in ligature group (p <0.05), NO was higher in ligature + L - Arg + Losartan group than that in ligature group (p <0.05). O_2^- was higher in ligature group and ligature + L - Arg group than that in control group (p < 0. 05), O_2^- was lower in ligature + Losartan group than that in ligature group (p <0. 05). The level of SOD was lower in ligature group than that in control group (p <0.05), higher in ligature + L- Arg group and ligature + L - Arg + Losartan group than that in ligature group (p <0. 05). Conclusions AngⅡ,O_2^- and NO imbalance play an important role in hypertension pathogenesis, LArg and losartan may have protective effect. Objectives To study the changes of nitric oxide, angiotensin Ⅱ and superoxide anion in renal artery hypertension pathogenesis. Methods Male Wistar rats weighing 256 -285g were divided into 5 groups randomly, 10 rats of each group. Control group: false operation was made and routine diet was given; Ligature group: left renal artery was ligatured uncompletely and routine diet was given; Ligature + Losartan group: left renal artery was ligatured uneompletely and Losartan 20mg · kg^(-1) · d^(-1) was added in the drinking water; Ligature + L -Arg group: left renal artery was ligatured uncompletely and L -Arg 2g · kg^(-1) · d^(-1) was added in the drinking water; Ligature + L - Arg + Losartan group: left renal artery was ligatured uncompletely and L - Arg 2g· kg^(-1)· d^(-1) and Losartan 20mg · kg^(-1)· d^(-1) was added in the drinking water. Blood pressure and heart rate were measured before and at the end of the experiment. One week after ligature, blood was drawn to determine angiotensin Ⅱ, cGMP, nitric oxide, nitric oxide synthase (NOS), O_2^-, superoxide dismutase (SOD). Results Systolic blood pressure was higher in ligature group than that in control group (p <0.05), systolic blood pressure was much lower in ligature + Losartan group than that in ligature group. Heart rate did not change significantly after experiment (p > 0. 05). AngⅡ was higher in ligature group than that in control group, even much higher in ligature + Losartan group (p < 0. 01 ). There was no difference of cGMP in each group (p >. 05). The concentration of NO was lower in ligature group (p <0.05), NO was higher in ligature + L - Arg + Losartan group than that in ligature group (p <0.05). O_2^- was higher in ligature group and ligature + L - Arg group than that in control group (p < 0. 05), O_2^- was lower in ligature + Losartan group than that in ligature group (p <0. 05). The level of SOD was lower in ligature group than that in control group (p <0.05), higher in ligature + L- Arg group and ligature + L - Arg + Losartan group than that in ligature group (p <0. 05). Conclusions AngⅡ,O_2^- and NO imbalance play an important role in hypertension pathogenesis, LArg and losartan may have protective effect.
出处 《South China Journal of Cardiology》 CAS 2003年第2期115-118,共4页 岭南心血管病杂志(英文版)
关键词 superoxide anion·nitric oxide hypertension·angiotensin superoxide anion·nitric oxide hypertension·angiotensin Ⅱ
  • 相关文献

参考文献4

  • 1Stroth U,Unger T.The renin-angiotensin system and its receptors[].Journal of Cardiovascular Pharmacology.1999
  • 2Sun Y-P,Zhu B-Q,Browne AEM,et al.L-arginine decreases blood pressure and left ventricular hypertrophy in rats with experimental aortic coarctation[].Journal of the American College of Cardiology.
  • 3Guzik TJ,West NE,Pillai R. et al.Nitric oxide modulates ??superoxide release and peroxynitrite formation in human blood vessels[].Journal of Hypertension.2002
  • 4Dahlf B,Devereux RB,Kjeldsen SE,et al.Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) : a randomized trial against atenolol[].The Lancet.2002

同被引文献84

  • 1杨云,霍志成,彭健,贾满盈,黄铮,王智明,陈玉兰.氯沙坦对犬缺血再灌注心肌损伤的保护作用[J].第一军医大学学报,2005,25(5):580-581. 被引量:6
  • 2宋有城,万立礼,胡桃红,朱俊,王莉,李晶.充血性心力衰竭患者心率变异性分析[J].中华心血管病杂志,1995,23(2):107-109. 被引量:58
  • 3达娃次仁,赵锋.血管紧张素转换酶抑制剂及血管紧张素受体阻断剂对房颤的预防作用[J].中国心血管病研究,2006,4(11):857-859. 被引量:5
  • 4蔡庆勇,梁贵友,牛义民,高振宇,宋宣统.体外循环心肌胰岛素抵抗的实验研究[J].合肥医学院学报,2006,29(4):347-350. 被引量:15
  • 5Kuo CT,Luqman N,Lin KH,et al.Atrial fibrillation:new horizons[J].Chang Gung Med,2003,26(10):712-721.
  • 6Hirayama Y,Atarashi H,Kobayashi Y,et al.Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation[J].Circ,2005,69(6):671-676.
  • 7Komatsu T,Tachibana H,Sato Y,et al.Long-term efficacy of upstream therapy using angiotensin-converting enzyme inhibitors and statins in combination with antiarrhythmic agents for the treatment of paroxysmal atrial fibrillation[J].Int Heart,2009,50(4):465-476.
  • 8Anis RR.Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation[J].Exp Clin Cardiol,2009,14(1):1-7.
  • 9Hirayama Y,Atarashi H,Kobayashi Y,et al.Long-term effects of upstream therapy on paroxysmal atrial fibrillation in patients without overt heart diseases[J].Int Heart,2009,50(2):141-151.
  • 10Morishima M,Wang Y,Akiyoshi Y,et al.Telmisartan,an angiotensin Ⅱ type 1 receptor antagonist,attenuates T-type Ca2+ channel expression in neonatal mt cardiomyocytes[J].Eur Pharmacol,2009,609(1/3):105-112.

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部